156 related articles for article (PubMed ID: 9115966)
21. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
22. Acute promyelocytic leukemia with i(17)(q10) on G-banding and PML/RARA rearrangement by RT-PCR without evidence of PML/RARA rearrangement on FISH.
Huh J; Moon H; Chi H; Chung W
Int J Lab Hematol; 2009 Jun; 31(3):372-4. PubMed ID: 18294238
[No Abstract] [Full Text] [Related]
23. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
de Thé H
C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia.
Schad CR; Hanson CA; Paietta E; Casper J; Jalal SM; Dewald GW
Mayo Clin Proc; 1994 Nov; 69(11):1047-53. PubMed ID: 7967757
[TBL] [Abstract][Full Text] [Related]
25. Atypical t(15;17)(q13;q12) in a patient with all-trans retinoic acid refractory secondary acute promyelocytic leukemia: a case report and review of the literature.
Kurian S; Hogan TF; Bleigh OC; Dowdy YG; Merghoub T; Pandolfi PP; Wenger SL
Cancer Genet Cytogenet; 2002 Oct; 138(2):143-8. PubMed ID: 12505260
[TBL] [Abstract][Full Text] [Related]
26. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
27. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
Abe S; Ishikawa I; Harigae H; Sugawara T
Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
[TBL] [Abstract][Full Text] [Related]
28. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
29. Isochromosome 17q- in acute promyelocytic leukemia. Molecular characterization by fluorescence in situ hybridization.
Aventín A; Espadaler M; Martín-Henao GA; Mecucci C
Cancer Genet Cytogenet; 1994 Nov; 78(1):112-3. PubMed ID: 7987799
[No Abstract] [Full Text] [Related]
30. Differentiation therapy of acute promyelocytic leukemia.
Chen Z
Chin Med J (Engl); 1996 Mar; 109(3):179-82. PubMed ID: 8758302
[No Abstract] [Full Text] [Related]
31. Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy.
Peterson JF; He RR; Nayer H; Cuevo RS; Smadbeck JB; Vasmatzis G; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB
Cancer Genet; 2019 Sep; 237():51-54. PubMed ID: 31447065
[TBL] [Abstract][Full Text] [Related]
32. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
[TBL] [Abstract][Full Text] [Related]
33. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
[No Abstract] [Full Text] [Related]
34. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
35. PML/RAR alpha + ATRA = CR. A comment on acute promyelocytic leukaemia: molecular pathology and treatment.
Dyer MJ
Eur J Cancer; 1994; 30A(5):573-4. PubMed ID: 8080665
[No Abstract] [Full Text] [Related]
36. Simultaneous detection of type A and type B PML/retinoic acid receptor alpha fusion transcripts in acute promyelocytic leukemia.
Kohli V; Koller CA
Blood; 1995 Feb; 85(3):854-5. PubMed ID: 7833490
[No Abstract] [Full Text] [Related]
37. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
38. [All-trans-retinoic acid in the treatment of promyelocytic leukemia].
Nousiainen T; Jantunen E
Duodecim; 1993; 109(16):1410-4. PubMed ID: 7720600
[No Abstract] [Full Text] [Related]
39. ATRA is effective to an acute promyelocytic leukemia patient without RARA gene rearrangement.
Song X; Gong S; Chen J; Gao L; Yang J; Wang J
Leuk Res; 2010 Aug; 34(8):e190-3. PubMed ID: 20189646
[No Abstract] [Full Text] [Related]
40. Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by chemotherapy.
Nemet D; Grahovac B; Labar B; Mrsić M; Radman I; Bogdanić V; Hitrec V; Zaher D; Aurer I; Sertić D
Haematologica; 1995; 80(3):238-40. PubMed ID: 7672716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
